key: cord-0754215-rkduc85h authors: Lopez, Raymond A.; Padilla, Luz A.; Sorabella, Robert A.; Cleveland, David C.; Rhodes, Leslie A.; Dabal, Robert J. title: Tachyarrhythmia as a possible symptom of coronavirus in a neonate diagnosed with transposition of the great arteries date: 2021-04-16 journal: J Card Surg DOI: 10.1111/jocs.15574 sha: 1dd2767fb1b33e572e05231f1fa89e89e3e3a6f5 doc_id: 754215 cord_uid: rkduc85h BACKGROUND: The coronavirus disease 2019 (COVID‐19) pandemic poses broad challenges to healthcare systems and providers. The manifestations of this disease are still being described in a variety of different contexts and patient populations. RESULTS: We report the case of a neonate who demonstrated COVID‐19 after surgical correction of transposition of the great arteries. In addition, the patient demonstrated an evolving and persistent tachyarrhythmia consistent with neither the most likely postoperative complications nor typical COVID‐19. DISCUSSION: The patient had negative preoperative testing for the virus and presented with profound oxygen desaturation and respiratory failure several days postoperatively. This raised concern for a complication of his arterial switch operation. It was found that one of the patient's caregivers was an asymptomatic carrier of COVID‐19, and imaging ruled out intracardiac shunting. After initiating treatment for COVID‐19, the patient's oxygen requirements and need for anti‐arrhythmic agents improved. CONCLUSION: We propose that, despite negative preoperative testing, coronavirus infection may present as refractory tachyarrhythmia, and may be considered along with surgical complications as a cause for unexplained hypoxemia postoperatively. In June 2020, a 6-day-old full-term infant diagnosed with transposition of the great arteries underwent an arterial switch operation (ASO) with closures of a large ventricular septal defect and a secundum atrial septal defect. The postnatal course before surgery was uneventful and the infant was tolerating oral feeds on room air. The findings of preoperative computed tomography angiography included side-by-side great vessels with slightly malaligned commissures and a circumflex taking off from the right coronary artery, all of which were confirmed intraoperatively. Following removal of the cross-clamp (time = 82 min) and cardiopulmonary bypass (time = 114 min), it was observed that the patient had a brief period of complete atrioventricular block that evolved into tachyarrhythmia before leaving the operating room. The patient was admitted to the cardiovascular intensive care unit where he remained intubated, on low-dose milrinone, epinephrine, and a nitroglycerin drip. Later that day (postoperative day [POD] 0), the patient developed junctional ectopic tachycardia (JET) and right bundle branch block with a heart rate of 180-200 bpm. On POD 1, the persistent tachyarrhythmia and hypotension required the initiation of amiodarone boluses and procainamide drip for the former, and a vasopressin drip for the latter. On POD 2, the patient developed lactic acidosis, and atrial pacing was begun. Two days later, the patient's leukopenia and thrombocytopenia led to the patient receiving broadspectrum antibiotics and work-up for culture-negative sepsis. On The index of suspicion for a complication of the patient's ASO was high, and a bubble study ruled out left-to-right shunts as a cause of the hypoxemia. Persistent desaturation in the setting of a pandemic led to the patient's isolation, the initiation of IV heparin, and the collection of nasopharyngeal swabs from the patient, all staff members exposed to the infant, and the mother for reverse transcription COVID-19 polymerase chain reaction testing. Of all of those tested, only the infant and asymptomatic mother were positive for COVID-19 infection. On POD 14, ferritin measured 1982 ng/ml and LDH was 627 U/L, raising concern for multisystem inflammatory syndrome in children (MIS-C). Rheumatology and infectious disease were consulted, and these services recommended starting anakinra 15 mg every 12 hours, decadron, and surfactant. On POD 15, the infant began a course of remdesivir with 5 mg/kg on the first day, then 2.5 mg/kg daily. Over the subsequent 4-5 days, the patient's condition stabilized and improved. The JET remained controlled, and on POD 17, the patient was switched to oral amiodarone. On POD 24, the heparin and remdesivir were discontinued, and the following day the patient was weaned off of all vasoactive medication. On POD 26, the patient was extubated and placed on high-flow oxygen, progressing to lowflow nasal cannula by POD 30. Despite substantial improvements in the clinical status, the infant continued to test positive for COVID-19 for almost 3 weeks. Following two successive negative tests on consecutive days, the isolation status was removed on POD 40. The overall improvement and down-trending brain natriuretic peptide levels led to discontinuation of the amiodarone on POD 43, and the infant was discharged to home care on POD 48. COVID-19: crisis management in congenital heart surgery The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application Prevalence and cause of early Fontan complications: does the lymphatic circulation play a role? Arrhythmias and intracardiac conduction after the arterial switch operation Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Anakinra for severe forms of COVID-19: a cohort study Risk factors, prophylaxis, and treatment of venous thromboembolism in congenital heart disease patients COVID-19 as a confounding factor in a child submitted to staged surgical palliation of hypoplastic left heart syndrome: one of the first reports of SARS-CoV-2 infection in patients with congenital heart disease SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2 Tachyarrhythmia as a possible symptom of coronavirus in a neonate diagnosed with transposition of the great arteries The authors declare that there are no conflict of interests.